Terns Pharmaceuticals Inc — キャッシュフロー (NASDAQ:TERN) | MetaTrader

チャート全体を表示

Financials

概要明細書統計

営業活動によるキャッシュフロー -41.83 M-49.11 M-67.39 M-70.02 M-82.18 M -82.18 M 投資活動によるキャッシュフロー -119.7 M-22.27 M-37.99 M-12.41 M-298.04 M -298.04 M 財務活動によるキャッシュフロー 134.39 M167.09 M41.95 M164 M743.51 M 743.51 M フリーキャッシュフロー -42.17 M-49.38 M-67.44 M-70.06 M-82.18 M -82.18 M

ニュース

Big Pharma Is Thinking Small on Deals. That’s a Boon for Biotech.

Merck & Co.'s Quarterly Earnings Preview: What You Need to Know

AZN vs. MRK: Which Oncology Stock Offers Better Investment Potential?

Biotech Is Holding Steady In 2026 (NASDAQ:IBB)

Stock Market Breaks Lower As Oil Prices Rebound Amid Iran War; Arm Flexes: Weekly Review

Can MRK's Ongoing M&A Push Aid Long-Term Growth Ahead of Keytruda LOE?

Merck Stock Soars 50% in 6 Months: Buy, Hold, or Take Profits?

Merck to Boost Oncology Pipeline With $6.7B Terns Buyout, Stock Up

このクアルコムのアナリストはもはや強気ではない ; 木曜日の格下げ上位4件は以下の通り

Merck's Deal For Terns And Its Stellar CML Drug Candidate Looks Like Good Business (MRK)

Why Merck Might Have A Fight On Its Hands With Its $6.7 Billion Takeover Of Terns

Merck makes a big move into new cancer treatments with a $6.7 billion buyout deal